Cumberland Research Associates (United States)

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

Rohit Loomba, Mazen Noureddin, Kris V. Kowdley et al. · Hepatology · 2020 · 260 citations

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial

Edward Gane, Kris V. Kowdley, David Pound et al. · Gastroenterology · 2016 · 60 citations · Full text

Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

Julius Wilder, Lennox J. Jeffers, Natarajan Ravendhran et al. · Hepatology · 2015 · 58 citations · Full text

The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease

John Poulos, Peter T. Kalogerinis, Valentin Milanov et al. · Journal of Dietary Supplements · 2021 · 12 citations

Nutrition, Fatty Liver Disease, Obesity +25

Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults

Jeffrey Medoff, Seymour Katz, Pramod Malik et al. · Clinical Therapeutics · 2004 · 10 citations

Urology, Gastrointestinal Pharmacology, Dose-ranging Pilot Study +6